Dipyridamole

Home
About
Help
History (1)
- Dipyridamole
- See All Pages

"Dipyridamole" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)

Descriptor ID	D004176
MeSH Number(s)	D03.383.742.175
Concept/Terms	Dipyridamole Dipyridamole Dipyramidole Apo-Dipyridamole Apo-Dipyridamole Apo Dipyridamole Cerebrovase Cerebrovase Persantine Persantine Persantin Curantil Curantil Curantyl Kurantil Miosen Miosen Novo-Dipiradol Novo-Dipiradol Novo Dipiradol Antistenocardin Antistenocardin Cléridium Cléridium

Below are MeSH descriptors whose meaning is more general than "Dipyridamole".

Chemicals and Drugs [D]
Heterocyclic Compounds [D03]
Heterocyclic Compounds, 1-Ring [D03.383]
Pyrimidines [D03.383.742]
Dipyridamole [D03.383.742.175]

Below are MeSH descriptors whose meaning is related to "Dipyridamole".

Below are MeSH descriptors whose meaning is more specific than "Dipyridamole".

Dipyridamole
Aspirin, Dipyridamole Drug Combination

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Dipyridamole" by people in this website by year, and whether "Dipyridamole" was a major or minor topic of these publications.

Bar chart showing 11 publications over 8 distinct years, with a maximum of 2 publications in 1996 and 2003 and 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	2	0	2
1998	1	0	1
2001	0	1	1
2003	0	2	2
2009	1	0	1
2010	0	1	1
2011	0	1	1
2013	2	0	2

Below are the most recent publications written about "Dipyridamole" by people in Profiles.

Mansoor AH, Mujtaba MT, Silver B. Antiplatelet therapy to prevent recurrent stroke: Three good options. Cleve Clin J Med. 2013 Dec; 80(12):787-95.

View in: PubMed
Malloy RJ, Kanaan AO, Silva MA, Donovan JL. Evaluation of antiplatelet agents for secondary prevention of stroke using mixed treatment comparison meta-analysis. Clin Ther. 2013 Oct; 35(10):1490-1500.e7.

View in: PubMed
Nawathe A, Ariyarajah V, Apiyasawat S, Barac I, Spodick DH. Correlation of echocardiographic left atrial abnormality with myocardial ischemia during myocardial perfusion assessment in the presence of known left ventricular hypertrophy. Am J Cardiol. 2013 Aug 01; 112(3):416-9.

View in: PubMed
Eikelboom JW, Hirsh J, Spencer FA, Baglin TP, Weitz JI. Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb; 141(2 Suppl):e89S-e119S.

View in: PubMed
Dixon BS, Beck GJ, Dember LM, Vazquez MA, Greenberg A, Delmez JA, Allon M, Himmelfarb J, Hu B, Greene T, Radeva MK, Davidson IJ, Ikizler TA, Braden GL, Lawson JH, Cotton JR, Kusek JW, Feldman HI. Use of aspirin associates with longer primary patency of hemodialysis grafts. J Am Soc Nephrol. 2011 Apr; 22(4):773-81.

View in: PubMed
Maron BA, Shekar PS, Goldhaber SZ. Paradoxical embolism. Circulation. 2010 Nov 09; 122(19):1968-72.

View in: PubMed
Stern DR, Kazam J, Edwards P, Maybaum S, Bello RA, D'Alessandro DA, Goldstein DJ. Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD. J Card Surg. 2010 May; 25(3):352-6.

View in: PubMed
Dixon BS, Beck GJ, Vazquez MA, Greenberg A, Delmez JA, Allon M, Dember LM, Himmelfarb J, Gassman JJ, Greene T, Radeva MK, Davidson IJ, Ikizler TA, Braden GL, Fenves AZ, Kaufman JS, Cotton JR, Martin KJ, McNeil JW, Rahman A, Lawson JH, Whiting JF, Hu B, Meyers CM, Kusek JW, Feldman HI. Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med. 2009 May 21; 360(21):2191-201.

View in: PubMed
Chakrabarti S, Freedman JE. Dipyridamole, cerebrovascular disease, and the vasculature. Vascul Pharmacol. 2008 Apr-Jun; 48(4-6):143-9.

View in: PubMed
Phillips RA. A review of therapeutic strategies for risk reduction of recurrent stroke. Prog Cardiovasc Dis. 2008 Jan-Feb; 50(4):264-73.

View in: PubMed

People

Explore

Similar Concepts

Top Journals